DXC Technology (DXC)
NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
$14.88+7.98%
Close 2026-11-04 · 1-day change
NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
Research Workspace
Put DXC beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
IT Consulting & Other Services is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Free cash flow at least $600 million in fiscal 2027: Free cash flow: $143M.
View ThesisRevenue is contracting — down about 3% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 18%.
View QualityManagement screens strong on earnings delivery, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 47% in its worst 12-month stretch.
View RiskDXC's revenue is shrinking, so the claim rests on a cheap valuation. Recent revenue fell 4% year over year in the latest quarter. The company beat earnings estimates by 21.8% in that period. DXC trades at 5.3 times earnings versus a 13.7 peer median. The market expects less growth than our model forecasts. Free cash flow of $143M is far below the $600M target. This gap puts the core thesis pillar under pressure. Peer multiples imply a price about 64% above where it trades. The thesis is on watch, and this read is provisional.
Trailing returns as of 2026-11-04. DXC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 8 analysts currently covering DXC (as of Nov 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare DXC with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| DXC Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus IT Consulting & Other Services — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put DXC next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Improve revenue performance and restore growth
Full-year guidance cuts pressure growth recovery, though the headline’s valuation claim is analyst interpretation.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Improve revenue performance and restore growth
Forecast steep organic revenue decline and strategic options raise material growth and execution concerns.
Threatens: Improve revenue performance and restore growth
Weak outlook outweighs estimate beat, reinforcing concerns about restoring revenue growth.
Potential $2.4 billion unit sale could affect portfolio and capital allocation, but remains source-based.
Reuters reports sale talks that could reshape DXC, though no deal is confirmed.
Threatens: Enhance revenue growth
AI ambitions may not enhance revenue growth as expected.
Weak Q2 raises concerns about future growth potential.
Weak growth outlook impacts overall valuation attractiveness.